HITI NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

High Tide Inc · Healthcare · Pharmaceutical Retailers

Latest close 2.15 USD
-4.0% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -10.0% below the Trend Line and sits at 3.2% of its 52-week range. The latest completed week returned -4.0%, after a -4.0% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 56/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal; earnings are due in 45d.

Setup score 17 out of 100
Latest Close 2.15 USD 24 Jul 2026
1W Return -4.0% latest completed week
4W Return -4.0% short-term follow-through
12W Return -12.2% quarterly tape
Trend Breadth 26.9% 14 of 52 weeks active
Volume Ratio 0.5x vs 13-week average
What is working
  • No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Activity pressure is negative, which weakens the current setup.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -10.0% below the Trend Line and sits at 3.2% of its 52-week range. The latest completed week returned -4.0%, after a -4.0% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.5x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0312-week average 0.07

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure7/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -4.0% over four weeks, -12.2% over 12 weeks, and -6.9% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W-4.0%
4W-4.0%
12W-12.2%
26W-15.4%
52W-6.9%
Active trend streak0 weeks
Active weeks in one year14
Trend breadth26.9%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.54Latest activity-pressure read.
Pressure change-2565.3%Four-week change in activity pressure.
Leadership-26.75Latest relative-leadership reading.
RS change2.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Oct 2025 Field coverage 85% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength44/100Blend of value, momentum, and quality. Underlying universe rank 57; rank 1 is best.
Value78/100Relative valuation strength. Underlying universe rank 23; rank 1 is best.
Quality7/100Profitability and accounting quality. Underlying universe rank 94; rank 1 is best.
Momentum23/100Medium-term price momentum. Underlying universe rank 78; rank 1 is best.
Growth80/100Revenue and earnings growth. Underlying universe rank 21; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.3x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
10.9%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
21.7%
Gross profit retained from each unit of revenue.
Operating margin
-4.4%
Operating profit retained from revenue.
Free-cash-flow margin
5.3%
Free cash flow generated from revenue.
Return on invested capital
-10.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
22.1%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-0.6%
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
0.7%
Cash dividends relative to market value.
Buyback yield
0.0%
Net share repurchases relative to market value.
Shareholder yield
0.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-45.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

HITI shows volatility options pressure with a 56/100 conviction score, put-call volume ratio of 0.00, expected move of 25.3%, and Sharemaestro trend signal inactive.

Conviction56/100
Expected move25.3%
Put/call volume0.00
Pressure100
Speculation18
Volatility96
Trend agreement0
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment58/100

Weighted news tone is neutral across 53 relevant articles.

23 positive · 29 neutral · 1 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings45dNext report is scheduled for 14 Sep 2026; event risk rises as the date approaches.
Options expected move25.3%Nearest-chain priced movement where available.
52-week drawdown-47.0%Distance below the 52-week high.
13-week volatility2.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2612 weeks finished lower.
Best week+7.8%Week of 20 Feb.
Worst week-12.2%Week of 30 Jan.
Latest week-4.0%Week of 24 Jul.

Shape of recent returns

Strong gains3
Modest gains10
Flat weeks1
Modest losses8
Sharp losses4
Recent vol2.9%13-week weekly-return volatility.
Base vol7.5%52-week weekly-return volatility.
Up/down split21/29Count of positive and negative weeks in the 52-week window.
Average skew5.8% / -4.0%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 20262.15 USD-4.0%2.39 USD2.32 USD-0.54-26.751.2MOff
17 Jul 20262.24 USD1.4%2.41 USD2.32 USD-0.28-25.222.2MOff
10 Jul 20262.21 USD-3.9%2.43 USD2.31 USD-0.04-29.661.1MOff
3 Jul 20262.30 USD2.7%2.45 USD2.30 USD0.06-25.871.2MOff
26 Jun 20262.24 USD-3.0%2.46 USD2.30 USD-0.02-27.493.3MOff
19 Jun 20262.31 USD0.0%2.47 USD2.29 USD0.07-28.8914.4MOff
12 Jun 20262.31 USD0.9%2.48 USD2.28 USD-0.00-27.341.5MOff
5 Jun 20262.29 USD-6.5%2.50 USD2.28 USD0.16-26.671.7MOff
29 May 20262.45 USD2.5%2.52 USD2.27 USD0.41-25.491.9MOff
22 May 20262.39 USD-0.8%2.54 USD2.26 USD0.40-25.541.2MOff
15 May 20262.41 USD-4.0%2.57 USD2.26 USD0.54-24.382.0MOff
8 May 20262.51 USD2.4%2.60 USD2.25 USD0.42-21.881.9MOff
1 May 20262.45 USD-0.8%2.63 USD2.24 USD0.12-20.041.8MOff
24 Apr 20262.47 USD1.6%2.67 USD2.23 USD-0.15-18.583.4MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.